Your browser doesn't support javascript.
loading
Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis.
Haas, David W; Mngqibisa, Rosie; Francis, Jose; McIlleron, Helen; Robinson, Jennifer A; Kendall, Michelle A; Baker, Paxton; Mawlana, Sajeeda; Badal-Faesen, Sharlaa; Angira, Francis; Omoz-Oarhe, Ayotunde; Samaneka, Wadzanai P; Denti, Paolo; Cohn, Susan E.
Afiliação
  • Haas DW; Department of Medicine, Vanderbilt University School of Medicine.
  • Mngqibisa R; Department of Internal Medicine, Meharry Medical College, Nashville, Tennessee, USA.
  • Francis J; Enhancing Care Foundation, Durban International CRS, Wentworth Hospital, Durban.
  • McIlleron H; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Robinson JA; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Kendall MA; Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Baker P; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Mawlana S; Vanderbilt Technologies for Advanced Genomics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Badal-Faesen S; Enhancing Care Foundation, Durban International CRS, Wentworth Hospital, Durban.
  • Angira F; Clinical HIV Research Unit, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Omoz-Oarhe A; Kenya Medical Research Institute, Center for Global Health Research (KEMRI/CGHR)/Emory-CDC CTU, Kisumu, Kenya.
  • Samaneka WP; Botswana Clinical Trials Unit, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Denti P; Parirenyatwa CRS, University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.
  • Cohn SE; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Pharmacogenet Genomics ; 32(1): 24-30, 2022 01 01.
Article em En | MEDLINE | ID: mdl-34369424

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções por HIV Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Pharmacogenet Genomics Assunto da revista: FARMACOLOGIA / GENETICA MEDICA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções por HIV Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Pharmacogenet Genomics Assunto da revista: FARMACOLOGIA / GENETICA MEDICA Ano de publicação: 2022 Tipo de documento: Article